-Bloomberg
https://www.bloomberg.com/news/articles/2022-11-16/novartis-is-said-to-weigh-ophthalmology-respiratory-unit-sales#xj4y7vzkg
Regulatory Setback For Medtronic’s High Blood Pressure Device – FDA Backed Japanese Firms’ Similar Device For Uncontrolled Hypertension
Medtronic Plc (NYSE: MDT) says the FDA Circulatory System Devices Panel (CSDP) voted unanimously (13-0) on safety and in favor (7-6) of the effectiveness of the Symplicity blood pressure procedure,
